Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The website has added information about 3 more interventions/treatments and updated the study to include 73 locations, while also revising the version from v2.9.7 to v2.10.0.
    Difference
    0.5%
    Check dated 2024-07-23T15:01:05.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:30:52.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:40:56.000Z thumbnail image
  8. Check
    26 days ago
    Change Detected
    Summary
    The value 'Last Update Posted (Estimated)' has been changed to 'Last Update Posted'. This change indicates that the last update posted on the webpage is now based on actual data rather than an estimated date.
    Difference
    0.0%
    Check dated 2024-07-01T13:14:16.000Z thumbnail image
  9. Check
    28 days ago
    Change Detected
    Summary
    The value that was previously listed as Last Update Posted on 2024-01-22 has been updated to Last Update Posted (Estimated) on 2024-06-28. This change indicates a recent update in the study record information related to the clinical trial for evaluating the efficacy and safety of pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen in recurrent or metastatic head and neck squamous cell carcinoma.
    Difference
    0.6%
    Check dated 2024-06-29T12:32:16.000Z thumbnail image
  10. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T10:42:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.